Experimental Hereditary Angioedema Treatment Performs Well in Phase 2 Trial
source: pixabay.com

Experimental Hereditary Angioedema Treatment Performs Well in Phase 2 Trial

According to a story from PR Newswire, the biotechnology company Ionis Pharmaceuticals recently announced promising findings from its phase 2 clinical trial. This clinical trial was evaluating the company's experimental…

Continue Reading Experimental Hereditary Angioedema Treatment Performs Well in Phase 2 Trial